TECX Q1 2024 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$13M

Net Income

-$15M

EPS (Diluted)

$-1.82

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$321,000

Balance Sheet

Total Assets

$92M

Total Liabilities

$4M

Stockholders' Equity

$89M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$920,000	+100.0%
Operating Income	-$13M	-$25M	+48.6%
Net Income	-$15M	-$25M	+39.0%